9.2 C
New York
HomeTop Global NewsHealthcareLilly trades at a premium to Ozempic-maker Novo as obesity drugs boom

Lilly trades at a premium to Ozempic-maker Novo as obesity drugs boom




Source link

latest articles

explore more

LEAVE A REPLY

Please enter your comment!
Please enter your name here